Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05655325 · ClinicalTrials.gov registry record · NA

Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity

A NA study of Mild Cognitive Impairment and Chronic Kidney Diseases, sponsored by Columbia University.

Recruiting
Registry status
NA
Development phase
144
Enrollment target
1
Study location

NCT05655325 is a NA study of Mild Cognitive Impairment and Chronic Kidney Diseases that is actively recruiting participants, run by Columbia University. The registered enrollment target is 144 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05655325, a NA study of Mild Cognitive Impairment and Chronic Kidney Diseases, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
NA
Development phase
144 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see if 6 months of home-based walking will improve memory, and brain structure and function, compared to health education in older adults that have chronic kidney disease and mild cognitive impairment.

Interventions

  • OTHER Attention control
  • BEHAVIORAL Home-based walking exercise

Study Locations (1)

New York

  • Columbia University - New York

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2024-06-18
Est. Completion 2027-02-01
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT05655325

The ClinicalTrials.gov registry entry for NCT05655325 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (89% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Attention control is the first listed.

NCT05655325 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05655325 about?

NCT05655325 is a clinical study titled "Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity". The purpose of this study is to see if 6 months of home-based walking will improve memory, and brain structure and function, compared to health education in older adults that have chronic kidney disease and mild cognitive impairment.

What is the current status of trial NCT05655325?

This trial is currently recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2024-06-18. Estimated completion is 2027-02-01.

What conditions does trial NCT05655325 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment, Chronic Kidney Diseases.

What interventions are being tested in trial NCT05655325?

The interventions under investigation include: Attention control (OTHER), Home-based walking exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT05655325?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05655325 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.